Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risks involved in selective decontamination in immunocompromised patients.

M A Boogaerts

    Mycoses
    |January 1, 1989
    PubMed
    Summary

    Selective decontamination strategies are crucial for preventing infections in immunocompromised patients. New antifungal drugs like itraconazole are needed as conventional options fall short.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Antifungal prophylaxis in neutropenia.

    Current opinion in infectious diseases·2006
    Same author

    Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftment.

    Leukemia & lymphoma·2002
    Same author

    Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same author

    NF-kappaB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells.

    Clinical and experimental immunology·2001
    Same author

    Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia.

    Nature genetics·2001
    Same author

    Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy.

    Antimicrobial agents and chemotherapy·2001

    Area of Science:

    • Medical Microbiology
    • Infectious Diseases
    • Immunology

    Background:

    • The rising number of immunocompromised patients necessitates effective infection prophylaxis.
    • Host defense relies on mucosal barriers and the phagocytic system.
    • Classifying immunodeficiency into minor, standard, and major stages aids in treatment planning.

    Purpose of the Study:

    • To discuss selective decontamination strategies for preventing bacterial and fungal infections.
    • To highlight the need for new antifungal agents due to limitations of conventional drugs.

    Main Methods:

    • Review of current literature on selective decontamination and host defense mechanisms.
    • Analysis of treatment strategies for immunocompromised patients.
    • Discussion of antifungal drug efficacy, including newer agents like itraconazole.

    Main Results:

    • Selective decontamination is a key consideration for infection prophylaxis in immunocompromised individuals.
    • Effective prophylaxis requires assessing both microbial presence and host immune status.
    • Conventional antifungals have limitations, indicating a need for novel therapeutic options.

    Conclusions:

    • Prophylaxis strategies must be tailored to the individual's immunodeficiency level and microbial exposure.
    • Invasive fungal infections remain a significant concern, driving the search for improved antifungal therapies.
    • Itraconazole represents a promising new drug for managing fungal infections in vulnerable patient populations.

    Related Experiment Videos